Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attal

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|November 1, 1994
Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alphaD Schlaifer, P Dumazer, N Spenatto, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
European Journal of Immunology|July 1, 1991
In vivo interleukin 6 gene expression in the tumoral environment in multiple myelomaM Portier, G Rajzbaum, X G Zhang, et al.
Bone Marrow Transplantation|August 1, 1991
Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapyM Attal, F Huguet, D Schlaifer, et al.
British Journal of Haematology|November 1, 1994
Epstein-Barr virus in familial Hodgkin's diseaseD Schlaifer, F Rigal-Huguet, A Robert, et al.
Leukemia|March 23, 1999
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)P Moreau, A Huynh, T Facon, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experienceJ Reiffers, A M Stoppa, M Attal, et al.
Leukemia|February 1, 1994
Antisense inhibition of myeloperoxidase increases the sensitivity of the HL-60 cell line to vincristineD Schlaifer, K Meyer, C Muller, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|November 1, 1994
Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alphaD Schlaifer, P Dumazer, N Spenatto, et al.
Blood|May 15, 1992
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseuseD Blaise, D Maraninchi, E Archimbaud, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
European Journal of Immunology|July 1, 1991
In vivo interleukin 6 gene expression in the tumoral environment in multiple myelomaM Portier, G Rajzbaum, X G Zhang, et al.
Bone Marrow Transplantation|August 1, 1991
Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapyM Attal, F Huguet, D Schlaifer, et al.
British Journal of Haematology|November 1, 1994
Epstein-Barr virus in familial Hodgkin's diseaseD Schlaifer, F Rigal-Huguet, A Robert, et al.
Leukemia|March 23, 1999
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)P Moreau, A Huynh, T Facon, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experienceJ Reiffers, A M Stoppa, M Attal, et al.
Leukemia|February 1, 1994
Antisense inhibition of myeloperoxidase increases the sensitivity of the HL-60 cell line to vincristineD Schlaifer, K Meyer, C Muller, et al.
Pageof 16